
MorningRX: August 24, 2023
CVS Health joins the biosimilar market, the FDA issues warning about contaminated eye drops, and the CDC says not to kiss your pet turtle because of salmonella.
CVS Health Launches Company Focused on Biosimilars
CVS Health is officially joining the biosimilar market with its new subsidiary company called Cordavis, according to a
"CVS Health has a history of bringing innovative solutions to the market that lower the cost of drugs and ensure people have access to the medications they need to stay healthy," Shawn Guertin, chief financial officer at CVS Health, said in a release. "Cordavis is a logical evolution for us and will help ensure sufficient supply of biosimilars in the U.S. and support this market now and in the future, while ultimately improving health outcomes and reducing costs for consumers."
FDA Issues Warning for Certain Eye Drop Products
The FDA has issued a warning for consumers not to use certain eye drop products due to possible bacterial and fungal contamination, according
CDC Advises Against Kissing or Snuggling Your Pet Turtle
The CDC is currently investigating a possible multistate outbreak of salmonella that has been linked to small pet turtles, according to a
Newsletter
Pharmacy practice is always changing. Stay ahead of the curve with the Drug Topics newsletter and get the latest drug information, industry trends, and patient care tips.